XRAY
XRAY
DENTSPLY SIRONA Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $961M ▲ | $175M ▼ | $-145M ▲ | -15.09% ▲ | $-0.73 ▲ | $-32M ▲ |
| Q3-2025 | $904M ▼ | $392M ▼ | $-427M ▼ | -47.23% ▼ | $-2.14 ▼ | $-114M ▼ |
| Q2-2025 | $936M ▲ | $618M ▲ | $-45M ▼ | -4.81% ▼ | $-0.23 ▼ | $-41M ▼ |
| Q1-2025 | $879M ▼ | $403M ▼ | $20M ▲ | 2.28% ▲ | $0.1 ▲ | $142M ▲ |
| Q4-2024 | $905M | $955M | $-430M | -47.51% | $-2.16 | $-419M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $326M ▼ | $5.43B ▼ | $4.09B ▼ | $1.34B ▼ |
| Q3-2025 | $363M ▲ | $5.65B ▼ | $4.17B ▲ | $1.48B ▼ |
| Q2-2025 | $359M ▼ | $6.07B ▲ | $4.11B ▲ | $1.96B ▼ |
| Q1-2025 | $398M ▲ | $6.05B ▲ | $4.04B ▲ | $2.01B ▲ |
| Q4-2024 | $272M | $5.75B | $3.81B | $1.94B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-145M ▲ | $101M ▲ | $-45M ▼ | $-99M ▼ | $-37M ▼ | $60M ▲ |
| Q3-2025 | $-427M ▼ | $79M ▲ | $-36M ▼ | $-36M ▲ | $4M ▲ | $40M ▲ |
| Q2-2025 | $-45M ▼ | $48M ▲ | $-34M ▼ | $-68M ▼ | $-39M ▼ | $16M ▲ |
| Q1-2025 | $19M ▲ | $7M ▼ | $-17M ▲ | $123M ▲ | $126M ▲ | $-12M ▼ |
| Q4-2024 | $-428M | $87M | $-57M | $-38M | $-24M | $36M |
Revenue by Products
| Product | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 |
|---|---|---|---|---|
Consumables Segment | $430.00M ▲ | $390.00M ▼ | $380.00M ▼ | $430.00M ▲ |
Technologies And Equipment | $590.00M ▲ | $560.00M ▼ | $600.00M ▲ | $550.00M ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Europe | $360.00M ▲ | $400.00M ▲ | $380.00M ▼ | $430.00M ▲ |
Other Foreign | $210.00M ▲ | $240.00M ▲ | $230.00M ▼ | $240.00M ▲ |
UNITED STATES | $300.00M ▲ | $290.00M ▼ | $290.00M ▲ | $300.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DENTSPLY SIRONA Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a strong revenue base, attractive gross margins, and a leading position in digital dental technology. The company enjoys broad product coverage, a powerful brand, and a sticky, integrated ecosystem that ties together equipment, software, and consumables. Liquidity is adequate, and the business continues to generate positive operating and free cash flow even in a loss-making year. Its sustained investment in innovation positions it well for ongoing shifts toward digital and AI-driven dentistry.
Major risks center on profitability and leverage. High overhead and non-operating costs have driven a large net loss, and cumulative negative retained earnings highlight historical challenges in turning scale into lasting earnings. Elevated debt levels increase financial risk and may limit flexibility if conditions deteriorate. Continued dividend payments despite losses can further strain the balance sheet. Externally, intense competition, fast-moving technology, and regulatory and economic pressures in healthcare add uncertainty to future performance.
The company’s long-term prospects hinge on whether it can align its strong strategic and technological position with a leaner, more efficient financial profile. If management can control costs, simplify operations, and gradually deleverage while continuing to advance its digital ecosystem, the business could move from a story of under-earning to one of monetizing its innovations more fully. Until there is clearer evidence of sustained margin improvement and better retention of profits, however, the outlook remains balanced between the promise of its market position and the constraints of its current financial profile.
About DENTSPLY SIRONA Inc.
https://www.dentsplysirona.comDENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $961M ▲ | $175M ▼ | $-145M ▲ | -15.09% ▲ | $-0.73 ▲ | $-32M ▲ |
| Q3-2025 | $904M ▼ | $392M ▼ | $-427M ▼ | -47.23% ▼ | $-2.14 ▼ | $-114M ▼ |
| Q2-2025 | $936M ▲ | $618M ▲ | $-45M ▼ | -4.81% ▼ | $-0.23 ▼ | $-41M ▼ |
| Q1-2025 | $879M ▼ | $403M ▼ | $20M ▲ | 2.28% ▲ | $0.1 ▲ | $142M ▲ |
| Q4-2024 | $905M | $955M | $-430M | -47.51% | $-2.16 | $-419M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $326M ▼ | $5.43B ▼ | $4.09B ▼ | $1.34B ▼ |
| Q3-2025 | $363M ▲ | $5.65B ▼ | $4.17B ▲ | $1.48B ▼ |
| Q2-2025 | $359M ▼ | $6.07B ▲ | $4.11B ▲ | $1.96B ▼ |
| Q1-2025 | $398M ▲ | $6.05B ▲ | $4.04B ▲ | $2.01B ▲ |
| Q4-2024 | $272M | $5.75B | $3.81B | $1.94B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-145M ▲ | $101M ▲ | $-45M ▼ | $-99M ▼ | $-37M ▼ | $60M ▲ |
| Q3-2025 | $-427M ▼ | $79M ▲ | $-36M ▼ | $-36M ▲ | $4M ▲ | $40M ▲ |
| Q2-2025 | $-45M ▼ | $48M ▲ | $-34M ▼ | $-68M ▼ | $-39M ▼ | $16M ▲ |
| Q1-2025 | $19M ▲ | $7M ▼ | $-17M ▲ | $123M ▲ | $126M ▲ | $-12M ▼ |
| Q4-2024 | $-428M | $87M | $-57M | $-38M | $-24M | $36M |
Revenue by Products
| Product | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 |
|---|---|---|---|---|
Consumables Segment | $430.00M ▲ | $390.00M ▼ | $380.00M ▼ | $430.00M ▲ |
Technologies And Equipment | $590.00M ▲ | $560.00M ▼ | $600.00M ▲ | $550.00M ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Europe | $360.00M ▲ | $400.00M ▲ | $380.00M ▼ | $430.00M ▲ |
Other Foreign | $210.00M ▲ | $240.00M ▲ | $230.00M ▼ | $240.00M ▲ |
UNITED STATES | $300.00M ▲ | $290.00M ▼ | $290.00M ▲ | $300.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DENTSPLY SIRONA Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a strong revenue base, attractive gross margins, and a leading position in digital dental technology. The company enjoys broad product coverage, a powerful brand, and a sticky, integrated ecosystem that ties together equipment, software, and consumables. Liquidity is adequate, and the business continues to generate positive operating and free cash flow even in a loss-making year. Its sustained investment in innovation positions it well for ongoing shifts toward digital and AI-driven dentistry.
Major risks center on profitability and leverage. High overhead and non-operating costs have driven a large net loss, and cumulative negative retained earnings highlight historical challenges in turning scale into lasting earnings. Elevated debt levels increase financial risk and may limit flexibility if conditions deteriorate. Continued dividend payments despite losses can further strain the balance sheet. Externally, intense competition, fast-moving technology, and regulatory and economic pressures in healthcare add uncertainty to future performance.
The company’s long-term prospects hinge on whether it can align its strong strategic and technological position with a leaner, more efficient financial profile. If management can control costs, simplify operations, and gradually deleverage while continuing to advance its digital ecosystem, the business could move from a story of under-earning to one of monetizing its innovations more fully. Until there is clearer evidence of sustained margin improvement and better retention of profits, however, the outlook remains balanced between the promise of its market position and the constraints of its current financial profile.

CEO
Simon D. Campion
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2006-07-18 | Forward | 2:1 |
| 2002-02-01 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 199
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Wells Fargo
Equal Weight
Evercore ISI Group
In Line
Baird
Neutral
B of A Securities
Buy
UBS
Buy
Mizuho
Neutral
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:22.01M
Value:$323.06M
BLACKROCK, INC.
Shares:19.81M
Value:$290.86M
BLACKROCK INC.
Shares:18.71M
Value:$274.68M
Summary
Showing Top 3 of 664

